HBK Sorce Advisory’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $944K | Sell |
12,402
-30
| -0.2% | -$2.87K | 0.02% | 255 |
|
|
2025
Q4 | $1.28M | Sell |
12,432
-619
| -5% | -$60.1K | 0.03% | 201 |
|
|
2025
Q3 | $1.24M | Sell |
13,051
-1,470
| -10% | -$135K | 0.03% | 200 |
|
|
2025
Q2 | $1.27M | Sell |
14,521
-1,229
| -8% | -$104K | 0.03% | 190 |
|
|
2025
Q1 | $1.42M | Sell |
15,750
-510
| -3% | -$45.6K | 0.04% | 177 |
|
|
2024
Q4 | $1.3M | Sell |
16,260
-3,086
| -16% | -$267K | 0.04% | 185 |
|
|
2024
Q3 | $1.74M | Sell |
19,346
-1,692
| -8% | -$142K | 0.05% | 151 |
|
|
2024
Q2 | $1.66M | Sell |
21,038
-1,518
| -7% | -$124K | 0.06% | 152 |
|
|
2024
Q1 | $1.97M | Sell |
22,556
-830
| -4% | -$70.8K | 0.07% | 148 |
|
|
2023
Q4 | $1.93M | Buy |
23,386
+2,055
| +10% | +$157K | 0.07% | 145 |
|
|
2023
Q3 | $1.67M | Buy |
21,331
+45
| +0.2% | +$3.77K | 0.07% | 144 |
|
|
2023
Q2 | $1.88M | Buy |
21,286
+24
| +0.1% | +$2.07K | 0.08% | 142 |
|
|
2023
Q1 | $1.71M | Sell |
21,262
-3,498
| -14% | -$285K | 0.08% | 151 |
|
|
2022
Q4 | $1.92M | Buy |
24,760
+5,267
| +27% | +$427K | 0.05% | 188 |
|
|
2022
Q3 | $1.57M | Buy |
19,493
+3,929
| +25% | +$353K | 0.11% | 133 |
|
|
2022
Q2 | $1.4M | Sell |
15,564
-8,748
| -36% | -$886K | 0.1% | 129 |
|
|
2022
Q1 | $2.7M | Buy |
24,312
+9,322
| +62% | +$985K | 0.15% | 102 |
|
|
2021
Q4 | $1.55M | Sell |
14,990
-7,207
| -32% | -$835K | 0.08% | 173 |
|
|
2021
Q3 | $2.78M | Buy |
22,197
+3,039
| +16% | +$393K | 0.15% | 101 |
|
|
2021
Q2 | $2.38M | Sell |
19,158
-143
| -0.7% | -$18K | 0.13% | 119 |
|
|
2021
Q1 | $2.28M | Buy |
19,301
+1,468
| +8% | +$172K | 0.14% | 114 |
|
|
2020
Q4 | $2.09M | Buy |
17,833
+5,495
| +45% | +$605K | 0.13% | 113 |
|
|
2020
Q3 | $1.28M | Buy |
12,338
+6,463
| +110% | +$649K | 0.09% | 142 |
|
|
2020
Q2 | $539K | Sell |
5,875
-2,485
| -30% | -$238K | 0.04% | 236 |
|
|
2020
Q1 | $754K | Buy |
8,360
+649
| +8% | +$69K | 0.07% | 161 |
|
|
2019
Q4 | $875K | Buy |
7,711
+2,708
| +54% | +$297K | 0.08% | 184 |
|
|
2019
Q3 | $543K | Sell |
5,003
-380
| -7% | -$39.6K | 0.05% | 241 |
|
|
2019
Q2 | $524K | Sell |
5,383
-336
| -6% | -$30.7K | 0.05% | 238 |
|
|
2019
Q1 | $521K | Buy |
5,719
+50
| +0.9% | +$4.47K | 0.05% | 243 |
|
|
2018
Q4 | $516K | Buy |
5,669
+924
| +19% | +$86.3K | 0.06% | 218 |
|
|
2018
Q3 | $467K | Sell |
4,745
-427
| -8% | -$39.5K | 0.05% | 230 |
|
|
2018
Q2 | $443K | Buy |
5,172
+159
| +3% | +$13.3K | 0.05% | 244 |
|
|
2018
Q1 | $402K | Sell |
5,013
-299
| -6% | -$24.7K | 0.05% | 246 |
|
|
2017
Q4 | $429K | Buy |
5,312
+1,923
| +57% | +$154K | 0.05% | 249 |
|
|
2017
Q3 | $263K | Buy |
3,389
+459
| +16% | +$38.1K | 0.04% | 267 |
|
|
2017
Q2 | $260K | Sell |
2,930
-155
| -5% | -$13.1K | 0.04% | 256 |
|
|
2017
Q1 | $249K | Buy |
+3,085
| New | +$241K | 0.04% | 264 |
|
|
2016
Q4 | – | Sell |
-2,758
| Closed | -$238K | – | 295 |
|
|
2016
Q3 | $238K | Buy |
+2,758
| New | +$240K | 0.05% | 253 |
|
|
2015
Q2 | – | Sell |
-7,591
| Closed | -$592K | – | 216 |
|
|
2015
Q1 | $592K | Buy |
7,591
+1,374
| +22% | +$104K | 0.2% | 83 |
|
|
2014
Q4 | $449K | Buy |
6,217
+1,616
| +35% | +$112K | 0.15% | 106 |
|
|
2014
Q3 | $285K | Sell |
4,601
-692
| -13% | -$44K | 0.1% | 129 |
|
|
2014
Q2 | $337K | Sell |
5,293
-25
| -0.5% | -$1.52K | 0.12% | 119 |
|
|
2014
Q1 | $327K | Buy |
5,318
+200
| +4% | +$11.7K | 0.12% | 114 |
|
|
2013
Q4 | $294K | Hold |
5,118
| – | – | 0.11% | 123 |
|
|
2013
Q3 | $273K | Sell |
5,118
-4,198
| -45% | -$226K | 0.11% | 127 |
|
|
2013
Q2 | $480K | Buy |
+9,316
| New | +$461K | 0.1% | 138 |
|
Other funds holding MDT
VCM
VPM
HBK Sorce Advisory's MDT Position: Q1 2026 in Review
HBK Sorce Advisory reduced its Medtronic (MDT) stake by 0.24% in Q1 2026, selling an estimated $2.87K and leaving 12,402 shares worth $944K. The position accounts for 0.02% of the portfolio, ranked #255.
HBK Sorce Advisory first reported a position in MDT in Q2 2013 and has held it in 46 quarters since. The position peaked at $2.78M in Q3 2021. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.
- HBK Sorce Advisory held 12,402 shares of Medtronic worth $944K as of Q1 2026.
- HBK Sorce Advisory sold 30 Medtronic shares in Q1 2026, an estimated $2.87K.
- Medtronic made up 0.02% of HBK Sorce Advisory's portfolio in Q1 2026, its #255 holding.
- HBK Sorce Advisory first reported a position in Medtronic in Q2 2013 and has held it in 46 quarters since.
- HBK Sorce Advisory's Medtronic position peaked at $2.78M in Q3 2021.
- 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.
Based on HBK Sorce Advisory's 13F filing for Q1 2026, filed 11 May 2026.